Duchenne muscular dystrophy (DMD) is a fatal X-linked disease caused by mutations in the DMD gene, leading to complete absence of dystrophin and progressive degeneration of skeletal musculature and myocardium.
The majority of DMD mutations are deletions of one or more exons, with a hotspot in the range of exons 45 to 55. Frame-shift mutations lead to the formation of a non-functional, truncated dystrophin or the complete absence of dystrophin due to premature stop-codons and - as a consequence - to severe muscular dystrophy. A prominent example is the loss of exon 52, which resembles one of the most frequent DMD mutations in humans.
Therefore, the research group has developed a porcine DMD model with this mutation, which mimics the biochemical, clinical and pathological hallmarks of the human disease but develops them in an accelerated mode.
In DMD patients and in the corresponding pig model with a deletion of DMD exon 52 (DMDD52), expression of an internally shortened dystrophin can be achieved by skipping of DMD exon 51 to reframe the transcript.
However, current delivery strategies for antisense oligonucleotides or gene editing tools limit exon skipping to a proportion of (cardio-)myocytes; the full therapeutic potential remains thus unclear.
Therefore, the research group generated a model of ubiquitous correction of DMD by systemic deletion of exon 51 in the dystrophic pig model lacking DMD exon 52. Molecular, pathological, and clinical alterations were largely rescued, supporting the optimization of exon skipping strategies as a clinically relevant goal.
Due to the high susceptibility of pigs to dystrophic muscle lesions, DMDD51-52 pigs resembling a form of Becker muscular dystrophy (BMD) will uncover long-term outcomes within a reasonable time frame.
This new study demonstrates that genetically tailored pig models are not only useful for studying disease mechanisms but also for predicting the best possible outcomes of targeted therapies.
https://www.pnas.org/doi/10.1073/pnas.2301250120
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fsystemic-deletion-of&filter=22
Deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model
- 1,162 views
- Added
Latest News
Circadian rhythm drives the…
By newseditor
Posted 21 Jun
Six distinct types of depre…
By newseditor
Posted 21 Jun
Key role of a growth factor…
By newseditor
Posted 21 Jun
Bidirectional BCI functiona…
By newseditor
Posted 19 Jun
Protein aggregation clock t…
By newseditor
Posted 19 Jun
Other Top Stories
Mitochondrial gene implicated in canine juvenile epilepsy
Read more
Genetic effects of Chernobyl radiation
Read more
GABAergic neuron development defect in CHARGE syndrome
Read more
Girls with mutations in the gene EPHB2 may be at increased risk of…
Read more
Neurodevelopmental genetic disease caused by mutations in RNA metab…
Read more
Protocols
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Publications
Programmed cell death: NINJ…
By newseditor
Posted 22 Jun
Circadian-clock-controlled…
By newseditor
Posted 21 Jun
Personalized brain circuit…
By newseditor
Posted 21 Jun
Alarmin S100A8 imparts chem…
By newseditor
Posted 21 Jun
BMP7 promotes cardiomyocyte…
By newseditor
Posted 21 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar